20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Diabetes Mellitus in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Azar, ST; Azar, TS; Azar, WS; Eid, AA; Hamdy, AF; Houeiss, P; Njeim, R; Noureldein, M; Rashid, A; Tamim, H; Zeidan, YH | 1 |
Jakstas, V; Kupstyte-Kristapone, N; Lesauskaite, V; Tatarunas, V; Zaliunas, R; Zvikas, V | 1 |
Xie, XN; Zhang, DH; Zhu, Y | 1 |
Bass, A; Edin, ML; Ellis, K; Hinderliter, AL; Lee, CR; Lih, FB; Poloyac, SM; Schuck, RN; Stouffer, GA; Theken, KN; Tomer, KB; Tran, B; Wu, MC; Zeldin, DC | 1 |
Abraham, NG; Gotlinger, KH; Guo, A; Hochhauser, E; Issan, Y; Kornowski, R; Laniado-Schwartzman, M; Leshem-Lev, D; Lev, E; Porat, E; Snir, E; Thompson, CI | 1 |
Carroll, MA; Ferreri, NR; McGiff, JC; Quilley, J | 1 |
2 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Diabetes Mellitus
Article | Year |
---|---|
[Progress in research of arachidonic acid-cytochrome P450 pathway in diabetes].
Topics: Animals; Arachidonic Acid; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Humans; Hydroxyeicosatetraenoic Acids; Insulin Resistance | 2011 |
Renal COX-2, cytokines and 20-HETE: tubular and vascular mechanisms.
Topics: Animals; Cyclooxygenase 2; Cytokines; Diabetes Mellitus; Glucocorticoids; Humans; Hydroxyeicosatetraenoic Acids; Ion Transport; Isoenzymes; Kidney; Kidney Tubules; Membrane Proteins; Microcirculation; Prostaglandin-Endoperoxide Synthases; Receptors, Calcium-Sensing; Tumor Necrosis Factor-alpha | 2004 |
4 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Diabetes Mellitus
Article | Year |
---|---|
Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease.
Topics: Diabetes Mellitus; Diabetic Nephropathies; Humans; Kidney; Prognosis; Prospective Studies | 2023 |
Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Blood Platelets; Cytochrome P450 Family 4; Diabetes Mellitus; Female; Humans; Hydroxyeicosatetraenoic Acids; Logistic Models; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors | 2020 |
Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
Topics: 8,11,14-Eicosatrienoic Acid; Age Factors; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Eicosanoids; Epoxide Hydrolases; Female; Humans; Hydroxyeicosatetraenoic Acids; Hydroxylation; Male; Middle Aged; North Carolina; Obesity; Regression Analysis; Risk Assessment; Risk Factors; Severity of Illness Index; Smoking; Tandem Mass Spectrometry | 2012 |
Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; AC133 Antigen; Aged; Antigens, CD; Body Mass Index; Cell Survival; Chromatography, Liquid; Diabetes Mellitus; Eicosanoids; Endothelial Cells; Female; Flow Cytometry; Glycoproteins; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipids; Male; Middle Aged; Myocardial Ischemia; Peptides; Stem Cells; Tandem Mass Spectrometry; Vascular Endothelial Growth Factor Receptor-2 | 2013 |